20240016787. METHODS FOR TREATMENT OF CANCER AND PHAGOCYTOSIS-DEFICIENCY RELATED DISEASES simplified abstract (RDiscovery, LLC)
Contents
METHODS FOR TREATMENT OF CANCER AND PHAGOCYTOSIS-DEFICIENCY RELATED DISEASES
Organization Name
Inventor(s)
Kazuhiko Nonomura of Chiba City (JP)
METHODS FOR TREATMENT OF CANCER AND PHAGOCYTOSIS-DEFICIENCY RELATED DISEASES - A simplified explanation of the abstract
This abstract first appeared for US patent application 20240016787 titled 'METHODS FOR TREATMENT OF CANCER AND PHAGOCYTOSIS-DEFICIENCY RELATED DISEASES
Simplified Explanation
The patent application describes methods for treating diseases and conditions associated with phagocytosis deficiency and methods for treating cancer using phagocytosis activating agents and mitochondrial fission inhibitors. These methods can be used as monotherapy or in combination with other agents. The application also includes agents, combinations of agents, and compositions for treating diseases associated with phagocytosis deficiency.
- Methods for treating diseases associated with phagocytosis deficiency and cancer using specific agents and inhibitors.
- The methods can be used as monotherapy or in combination with other agents.
- The patent application also includes agents, combinations of agents, and compositions for treating diseases associated with phagocytosis deficiency.
Potential applications of this technology:
- Treatment of diseases and conditions associated with phagocytosis deficiency, such as immunodeficiency disorders.
- Treatment of cancer using phagocytosis activating agents and mitochondrial fission inhibitors.
Problems solved by this technology:
- Phagocytosis deficiency can lead to various diseases and conditions, and this technology provides methods for treating them.
- Cancer can be difficult to treat, and this technology offers a new approach using phagocytosis activating agents and mitochondrial fission inhibitors.
Benefits of this technology:
- Provides new treatment options for diseases and conditions associated with phagocytosis deficiency.
- Offers a novel approach for treating cancer by targeting phagocytosis and mitochondrial fission.
- Can be used as monotherapy or in combination with other agents, allowing for personalized treatment approaches.
Original Abstract Submitted
methods for treating diseases and conditions associated with phagocytosis deficiency and methods for treating cancer with phagocytosis activating agents and mitochondrial fission inhibitors, respectively, as monotherapy or in combination with one or more additional agents, and agents, combinations of agents, and compositions for treating diseases and conditions associated with phagocytosis deficiency.
